Regeneron Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $1.95B | $5.61B | $809.1M |
| FY2016 | $2.52B | $6.97B | $535.2M |
| FY2017 | $2.62B | $8.76B | $812.7M |
| FY2018 | $2.98B | $11.73B | $1.47B |
| FY2019 | $3.72B | $14.81B | $1.62B |
| FY2020 | $6.14B | $17.16B | $2.19B |
| FY2021 | $6.67B | $25.43B | $2.89B |
| FY2022 | $6.55B | $29.21B | $3.11B |
| FY2023 | $7.11B | $33.08B | $2.73B |
| FY2024 | $8.41B | $37.76B | $2.49B |